CHNXF (ChitogenX) EBITDA Margin %: 0.00% (As of Oct. 2024)


What is ChitogenX EBITDA Margin %?

ChitogenX CHNXF EBITDA Margin % is 0.00% as of Oct. 2024.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ChitogenX's EBITDA for the three months ended in Oct. 2024 was $-0.28 Mil. ChitogenX's Revenue for the three months ended in Oct. 2024 was $0.00 Mil. Therefore, ChitogenX's EBITDA margin for the quarter that ended in Oct. 2024 was 0.00%.

ChitogenX  (OTCPK:CHNXF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ChitogenX EBITDA Margin % Related Terms

ChitogenX EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for ChitogenX's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChitogenX EBITDA Margin % Chart

ChitogenX Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

ChitogenX Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CHNXF vs SCPX, LADX, ENDV: EBITDA Margin % Comparison

For the Biotechnology subindustry, ChitogenX's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ChitogenX EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChitogenX's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ChitogenX's EBITDA Margin % falls into.


ChitogenX EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ChitogenX's EBITDA Margin % for the fiscal year that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2024 )/Revenue (A: Jan. 2024 )
=-0.499/0
= %

ChitogenX's EBITDA Margin % for the quarter that ended in Oct. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Oct. 2024 )/Revenue (Q: Oct. 2024 )
=-0.278/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
ChitogenX (CHNXF) has a EBITDA Margin % of 0.00% as of Oct. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ChitogenX and its competitors.
Is ChitogenX's EBITDA Margin % too high?
ChitogenX's current EBITDA Margin % is 0.00%.
How does ChitogenX's EBITDA Margin % compare to SCPX and LADX?
ChitogenX's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ChitogenX and its competitors. ChitogenX's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChitogenX stock overvalued right now?
ChitogenX (CHNXF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ChitogenX (CHNXF), the current EBITDA Margin % is 0.00% as of Oct. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ChitogenX Business Description

Address 16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9
ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.